key: cord-0886859-w3iewvqd
authors: Cheng, Linlin; Li, Haolong; Li, Liubing; Liu, Chenxi; Yan, Songxin; Chen, Haizhen; Li, Yongzhe
title: Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
date: 2020-10-19
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23618
sha: 27f8faf23386ce36c510a43e817da3f0e9832b38
doc_id: 886859
cord_uid: w3iewvqd

OBJECTIVE: The coronavirus disease 2019 (COVID‐19) has rapidly developed into a pandemic. Increased levels of ferritin due to cytokine storm and secondary hemophagocytic lymphohistiocytosis were found in severe COVID‐19 patients. Therefore, the aim of this study was to determine the role of ferritin in COVID‐19. METHODS: Studies investigating ferritin in COVID‐19 were collected from PubMed, EMBASE, CNKI, SinoMed, and WANFANG. A meta‐analysis was performed to compare the ferritin level between different patient groups: non‐survivors versus survivors; more severe versus less severe; with comorbidity versus without comorbidity; ICU versus non‐ICU; with mechanical ventilation versus without mechanical ventilation. RESULTS: A total of 52 records involving 10 614 COVID‐19‐confirmed patients between December 25, 2019, and June 1, 2020, were included in this meta‐analysis, and 18 studies were included in the qualitative synthesis. The ferritin level was significantly increased in severe patients compared with the level in non‐severe patients [WMD 397.77 (95% CI 306.51‐489.02), P < .001]. Non‐survivors had a significantly higher ferritin level compared with the one in survivors [WMD 677.17 (95% CI 391.01‐963.33), P < .001]. Patients with one or more comorbidities including diabetes, thrombotic complication, and cancer had significantly higher levels of ferritin than those without (P < .01). Severe acute liver injury was significantly associated with high levels of ferritin, and its level was associated with intensive supportive care, including ICU transfer and mechanical ventilation. CONCLUSIONS: Ferritin was associated with poor prognosis and could predict the worsening of COVID‐19 patients.

Since December 2019, the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly developed into a global outbreak characterized by a human-to-human transmission. 1 September 20, 2020. 3 Patients with comorbidities such as diabetes, cardiovascular disease, underlying respiratory diseases, and cancer are at high risk of severe complications and even death. This is a global crisis that requires the joint efforts of all mankind to fight it.

The cytokine storm is an uncontrolled and dysfunctional immune response in the immunopathogenic mechanism of COVID-19 similar to the one in severe influenza; inflammatory cytokines including TNF-α, IL-6, IL-12, and IL-8 are released in a massive amount during the disease progression, causing potential acute respiratory distress syndrome (ARDS) and systemic organ failure. [4] [5] [6] Evidence shows that the levels of serum ferritin, d-dimer, lactate dehydrogenase, and IL-6 are increased during the worsening of the disease, providing an indication of the risk of mortality. 6 Hyperferritinemia caused by the excessive inflammation due to the infection is associated with the admission to the intensive care unit and high mortality, and represents an indication to recognize high-risk patients to guide the therapeutic intervention to control inflammation. [7] [8] [9] Serum ferritin, a feature of hemophagocytic lymphohistiocytosis, which is a known complication of viral infection, is closely related to poor recovery of COVID-19 patients, and those with impaired lung lesion are more likely to have increased ferritin levels. 6, 10, 11 However, these studies were performed in a relatively small sample size and/or in a single center. Thus, as a pro-inflammatory factor in the uncontrolled cytokine storm, the predictive role of the ferritin level in the risk of poor outcome in COVID-19 patients requires further verification.

The laboratory tests combined with the clinical evaluation can allow a rapid assessment of the patient's condition to guide clinicians in finding the optimal approach and priority in these COVID -19 patients. Serum ferritin is particularly interesting due to its potential diagnostic and prognostic role. In this study, the current studies on COVID-19 were comprehensively investigated to determine the potential relationship of ferritin with severe condition, mortality, and other critical clinical features of COVID-19 patients.

The Preferred Reporting Items for Systematic Reviews and Meta-Analysis Diagnostic Test Accuracy (PRISMA-DTA) guideline 12 and Meta-analysis of Observational Studies in Epidemiology (MOOSE) 13 were followed to create this review. Seven databases such as PubMed, EMBASE, CNKI, SinoMed, and WANFANG were used to comprehensively search COVID-19-related studies. The searching items in all "fields" were the following: (coronavirus) OR (pneumonia) OR (nCoV) OR (HCoV) OR (SARS-CoV-2) OR (COVID) OR (NCP) AND ferritin. No restrictions were imposed regarding the language, region of the investigation, or ethnicity of the study population. The reference list of the included articles was also examined. The last retrieval time was August 16, 2020.

Eligible studies were those that investigated ferritin and its clinical relevance in patients diagnosed with COVID-19. The exclusion criteria were as follows: (1) review articles; (2) case reports; (3) studies without available laboratory data; (4) pre-printed articles without peer review; (5) incorrect study design or simple data presentation; and (6) patients age no more than 18 years. Two investigators independently performed the literature search, screening, full-text review, and the study quality assessment using the Newcastle-Ottawa Scale (NOS). Inter-researcher disagreement was resolved by consensus, or by the discussion with a third investigator.

Two independent investigators performed the data extraction, including date of publication, first author's name, region of the investigation, number of included cases, age (statistical significance), gender (statistical significance), ferritin level in the different groups (non-survivors vs. survivors; more severe vs. less severe; with comorbidity vs. without comorbidity; subjected to a certain treatment vs. without being subjected to a certain treatment), and diagnosis guideline. Primary data were extracted from the article text or tables. For further metaanalysis, categorical variables (such as gender, region of the investigation, comorbidities, symptoms, treatment, or endpoint events) are treated as dichotomous variables, while for continuous variables (such as age and ferritin results), median (interquartile range, IQR) or median (range) was converted to mean ± SD for meta-analysis according to Wan et al 14 . Any disagreement was resolved through discussion.

The meta-analysis was performed by Stata 12.0. The weighted mean difference (WMD) was used as the effect measure in the comparison between different patient groups. The random effects model was chosen for analysis, since it tends to generalize findings beyond the included studies by assuming that the selected studies are random samples from a larger population. 15 Heterogeneity among studies was evaluated using the Cochran's Q-statistic and I 2 -statistic.

P-values > .10 or I 2 > 50% were considered as indicating a significant heterogeneity. The sensitivity analysis was performed by leaveone-out analysis to evaluate the stability of the results. The random effects meta-regression was performed to explore the source of heterogeneity. Egger's test and funnel plot were used to examine the publication bias of the analysis according to Sterne et al. 16 were included. The repetition of patients from the same hospital was examined during the same period. Most of the selected studies (29/52) were performed in China. 6, [17] [18] [19] [20] [21] [22] [23] [24] [25] [27] [28] [29] [30] [31] [32] [35] [36] [37] 50, [59] [60] [61] [62] [63] [64] [65] [66] [67] Ten studies were performed in multicenters. 6, 17, 23, 34, 45, 49, 57, 58, 60, 64 Among the included studies, 17 compared the ferritin level between groups with different severity of COVID-19 [18] [19] [20] [21] [22] 34, 35, [37] [38] [39] 44, 50, 53, 56, 61, 64, 65 and 18 compared its level between non-survivors and survivors. 6, 17, 23, 24, [26] [27] [28] [29] [40] [41] [42] 45, 46, 52, 55, 58, 63, 66 The characteristics of all studies included in this meta-analysis are listed in Table 1 . The study quality performed by the NOS is shown in Table 2 . All studies were of high quality with a score from 7 to 9.

The forest plot showed that the ferritin level was significantly higher in more severe patients than that in less severe patients [WMD patients. 68 

The forest plot showed that the non-survivors with COVID-19 had 

Studies that determined the association of the ferritin level with baseline conditions (comorbidity, gender) were included in this meta-analysis ( Figure 6 ). Patients with one or more comorbidities including diabetes, thromboembolic events, and cancer had significantly higher levels of ferritin than those without (P < .01, 

Non-response rate Total score 

In the single-center study by Da et 

The ferritin level was found related to intensive supportive care in patients with diabetes, including ICU transfer ( Figure 7A) Ferritin is an iron-storing protein; its serum level reflects the normal iron level and helps the diagnosis of iron deficiency ane-

can be a marker of viral replication. 86 Hyperferritinemia, regardless of the presence of a tumor or rheumatic disease, is associated with the admission to the intensive care unit and high mortality. To be precise, the concentration of ferritin of more than 500 ng/mL predicts up to 58% mortality. 8, 9 As the immune status worsens, ferritin levels increase significantly in patients with sHLH compared with its level in patients with an immune dysregulated status. 89 Notably, the concentration of serum ferritin rarely reaches the HScore threshold (2000 ng/mL) within 16 days after the symptom onset, 6 which limit the early intervention to some extent, but the trend rather than the threshold of the laboratory results provides the most information. 100 Additionally, Li et al found that the ferritin level was the last laboratory value to return to normal compared with other acute proteins, and C-reactive protein returned to normal at least 5 days before ferritin did. 86 Similarly, other studies reported that only C-reactive protein rather than ferritin decreased significantly over time or after treatment. 101, 102 Therefore, the decrease at a lower rate limits the use for disease assessment. 

This meta-analysis revealed the association between the serum ferritin level and clinical characteristics of COVID-19 patients including disease severity, mortality, comorbidities, and certain treatments.

However, the ferritin test is frequently unavailable in an emer- 

This article does not contain any studies with human participants performed by any of the authors.

All data relevant to the study are included in the article or uploaded as supplementary information. 

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A novel coronavirus from patients with pneumonia in China

SARS-CoV-2 and viral sepsis: observations and hypotheses

Cytokine release syndrome in severe COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Hyperferritinemia and inflammation

Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients

A systemic inflammation mortality risk assessment contingency table for severe sepsis

Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China. medRxiv

COVID-19: consider cytokine storm syndromes and immunosuppression

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Conducting a meta-analysis: basics and good practices

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Clinical and immunological features of severe and moderate coronavirus disease 2019

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Clinical characteristics of 463 patients with common and severe type coronavirus disease 2019

Digestive system manifestations and analysis of disease severity in 54 patients with coronavirus disease 2019

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Diabetes is a risk factor for the progression and prognosis of COVID-19

Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy

Risk factors and their influence on the COVID-19 patients with different outcome

Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes

Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan

The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single-centre, retrospective, observational study in Wuhan

Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

The role of interleukin-6 in monitoring severe case of coronavirus disease 2019

Clinical characteristics of 28 patients with diabetes and COVID-19 in Wuhan

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19

Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA quarantine Hospital's patients, Egypt: a retrospective study

Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect

Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe

Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a Tertiary Care Center in Mexico City: a prospective cohort study

Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a Large Tertiary Center

A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity

The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

Takotsubo cardiomyopathy in COVID-19

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Predictors of coronavirus disease 2019 severity: A retrospective study of 64 cases

Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019

IL-6-based mortality risk model for hospitalized patients with COVID-19

Complement activation in patients with COVID-19: a novel therapeutic target

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

Letter to the editor: unexpected high mortality in COVID-19 and diabetic ketoacidosis

COVID-19 experience of the major pandemic response center in the capital: results of the pandemic's first month in Turkey

Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection

Appropriate use of tocilizumab in COVID-19 infection

Hyperglycemia is a strong predictor of poor prognosis in COVID-19

COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study

Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China

Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis

Critically ill patients with coronavirus disease 2019 in a designated ICU: clinical features and predictors for mortality

Serum ferritin as an independent risk factor for severity in COVID-19 patients

Study on early laboratory warning of severe COVID-19

Predictive value of multiple inflammatory indexes on the prognosis of patients with corona virus disease 2019

Analysis of clinical characteristics of patients with diabetes mellitus complicated with novel coronavirus pneumonia

Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing

Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19

Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy

Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study

Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Kinetic patterns of liver enzyme elevation with COVID-19 in the USA

Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience

Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large US cohort

Increased serum aminotransferase activity and clinical outcomes in coronavirus disease 2019

The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort

Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis

Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Use of tocilizumab in kidney transplant recipients with COVID-19

Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19

Retrospective analysis of laboratory testing in 54 patients with severe-or critical-type 2019 novel coronavirus pneumonia

Initial real-life experience from a designated COVID-19 Centre in Athens, Greece: a proposed therapeutic algorithm

Mild versus severe COVID-19: laboratory markers

Complex immune dysregulation in COVID-19 patients with severe respiratory failure

Regulation of ferritin genes and protein

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome

Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Endothelial cell infection and endotheliitis in COVID-19

COVID-19 and its implications for thrombosis and anticoagulation

Hemoglobin and ferritin concentrations are positively associated with blood pressure and hypertension risk in older adults: a retrospective cross-sectional study, Sharpeville, South Africa

Increased serum ferritin predicts the development of hypertension among middle-aged men

Elevated serum ferritin and mercury concentrations are associated with hypertension

Korea national health and nutrition examination survey

On the alert for cytokine storm: immunopathology in COVID-19

Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19

COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients